Evidence map›Paper›PMID 42911524›Full record

ArticleGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2026

Lipidomic profiling of peritoneal lavage supernatant identifies PE/PA/PI-enriched recurrence biomarkers in cytology-negative gastric cancer.

Lili Xu, Tomohito Sato, Chi Zhang, Ryo Omagari, Yutaka Takahashi, Atsushi Baba, Shoshiro Hirayama, Tomohiro Matsumoto, Ryoma Haneda, Wataru Soneda and 11 more

Abstract read
PubMed Publisher
In one paragraph

Article in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Lili XuDepartment of Cellular and Molecular Anatomy, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Tomohito SatoDepartment of Cellular and Molecular Anatomy, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Chi ZhangDepartment of Cellular and Molecular Anatomy, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Ryo OmagariDepartment of Cellular and Molecular Anatomy, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Yutaka TakahashiDepartment of Cellular and Molecular Anatomy, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Atsushi BabaDepartment of Cellular and Molecular Anatomy, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Shoshiro HirayamaDepartment of Cellular and Molecular Anatomy, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Tomohiro MatsumotoDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Ryoma HanedaDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Wataru SonedaDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Eisuke BookaDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Yuki SakaiDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Tomohiro MurakamiDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Takahiro WatanabeDepartment of Surgery, Shimada Municipal Hospital, 1200-5, Noda, Shimada, Shizuoka, Japan.
Masanori SatoDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Hirotoshi KikuchiDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Hiramatsu YohshiriroDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Tomoaki KahyoDepartment of Cellular and Molecular Anatomy, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Kazuma OkamotoDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Hiroya TakeuchiDepartment of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Mitsutoshi SetouDepartment of Cellular and Molecular Anatomy, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan. setou@hama-med.ac.jp.ORCID http://orcid.org/0000-0002-1302-6467

Funding

BRAIN JPJ009237Japan Agency for Medical Research and Development (AMED) JP24zf0127012Japan Agency for Medical Research and Development (AMED) JP25jf0126014Japan Agency for Medical Research and Development (AMED) JP26ak0101296Japan Society for the Promotion of Science JP23K17226Japan Society for the Promotion of Science (the Fujita Mind-BRIDGe of the J-PEAKS Program) JP22H02793
6 · The paper itself

Abstract

backgroundPeritoneal dissemination accounts for more than 40% of recurrences after radical gastrectomy for gastric cancer. Although peritoneal lavage cytology (CY) is routinely used to detect intraperitoneal free cancer cells, peritoneal recurrence still occurs in a subset of CY-negative patients. Novel molecular biomarkers are urgently needed to identify high-risk individuals within this cohort.

methodsDirect flow injection quadrupole time-of-flight mass spectrometry (DFI-Q-TOF-MS) in negative ion mode was applied to profile peritoneal lavage supernatants from gastric cancer patients stratified by recurrence outcome (CY-R + vs. CY-R-). Candidate recurrence-associated features were selected by volcano plot, LASSO logistic regression, and Random Forest. PLS-DA with VIP scores was applied for stage-associated feature identification.

resultsA recurrence-associated lipid signature was identified comprising phosphatidylethanolamine species (PE (34:0), PE (34:1), PE (38:1), PE O-38:5), phosphatidic acid PA (39:3), phosphatidylinositol PI (22:1), and oxidized sphingoid base SPB (18:3;O2), implicating membrane remodeling, lipid signaling pathway alterations, and oxidative stress in the peritoneal microenvironment of recurrence-prone patients.

conclusionThis study presents an exploratory lipidomic characterization of peritoneal lavage supernatant in CY-negative gastric cancer, identifying hypothesis-generating candidate lipid features associated with recurrence status. Given the small recurrence group and absence of external validation, all findings should be interpreted as exploratory and require confirmation in prospective multicenter studies.

Indexed as

Candidate biomarkersGastric cancerLipidomicsMass spectrometryPeritoneal lavagePeritoneal Recurrence

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.